scholarly article | Q13442814 |
P356 | DOI | 10.1016/0006-291X(77)90363-1 |
P698 | PubMed publication ID | 836321 |
P2093 | author name string | J. Spranger | |
J. Gehler | |||
M. Cantz | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 732-738 | |
P577 | publication date | 1977-01-01 | |
1977-01-24 | |||
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts | |
P478 | volume | 74 |
Q42440744 | A case of mucolipidosis II: Biochemical, nutritional, and immunological studies |
Q41554416 | A case of neuraminidase deficiency associated with a partial beta-galactosidase defect. Clinical, biochemical and radiological studies |
Q41491200 | A method for enrichment of hybrid somatic cells: complementation studies in certain lysosomal enzymopathies |
Q70283213 | A rapid and sensitive assay for neuraminidase using peanut lectin hemagglutination: Application to Vibrio cholera and Trypanosoma cruzi |
Q66953185 | A rapid and sensitive assay for neuraminidase: Application to cultured flbroblasts |
Q71144793 | A severe infantile sialidosis: clinical, biochemical, and microscopic features |
Q39291893 | Acid acylhydrolase deficiency in I-cell disease and pseudo-hurler polydystrophy |
Q39722186 | Adult type GMl-gangliosidosis: A complementation study on somatic cell hybrids |
Q66991225 | Adult type neuronal storage disease with neuraminidase deficiency |
Q72848920 | Affinity chromatography of lysosomal enzymes in plasma, urine and fibroblasts of patients with mucolipidosis (ML) II and III |
Q35966074 | Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry |
Q44007899 | Beta-galactosidase deficient-type mucolipidosis: A complementation study of neuraminidase in somatic cell hybrids |
Q67251308 | Biochemical basis of six different types of sialidosis |
Q70764611 | Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase |
Q36812239 | Catabolic disorders of complex carbohydrates |
Q43775457 | Cellular localization of neuraminidases in cultured human fibroblasts |
Q42875100 | Characterization of human placental neuraminidases. Stability, substrate specificity and molecular weight |
Q41607943 | Characterization of neuraminidase activity of cultured human fibroblasts |
Q39241410 | Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult |
Q28273887 | Combined deficiency of beta-galactosidase and neuraminidase: three affected siblings in a French family |
Q71132519 | Deficiency of methylumbelliferyl-alpha-Neuraminic acid neuraminidase in the sialidoses and mucolipidosis II and III |
Q71185005 | Deficiency of neuraminidase in the sialidoses and the mucolipidoses |
Q28302956 | Disorders of glycoprotein degradation |
Q41940652 | Effects of neuraminidase on the phenotype of sindbis virus grown in fibroblasts obtained from patients with I-cell disease |
Q90222396 | Exploration of the Sialic Acid World |
Q39618263 | GM1-gangliosidosis: Accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types |
Q24309596 | Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities |
Q52109078 | Genetic diagnostic studies for mental retardation. |
Q52104266 | Genetic heterogeneity in human neuraminidase deficiency. |
Q67262700 | I-cell disease Desialylation of β-hexosaminidase and its effect on uptake by fibroblasts |
Q41040230 | I-cell disease. A hypothesis for the structure of the carbohydrate recognition site on beta-D-N-acetylhexosaminidase |
Q41352808 | I-cell disease: Isoelectric focusing, concanavalin asepharose 4B binding and kinetic properties of human lier acid β-d-galactosidases |
Q34133659 | Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient. |
Q34480848 | Inborn errors of lysosomal catabolism—principles of heterozygote detection |
Q71065767 | Influence of sialic acid on cell surface properties in I-cell disease fibroblasts |
Q34498745 | Inherited lipid storage diseases of the central nervous system |
Q38357734 | Isolation and Characterization of Phosphorylated Oligosaccharides from alpha-N-Acetylglucosaminidase that Are Recognized by Cell-Surface Receptors |
Q34364491 | Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology |
Q39605242 | Macular cherry-red spots and myoclonus with dementia: Coexistent neuraminidase and β-galactosidase deficiencies |
Q36305733 | Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. |
Q43801611 | Mucolipidosis I — A sialidosis |
Q70659814 | Mucolipidosis I. Roentgenographic follow-up |
Q70757490 | Mucolipidosis I: Studies of sialidase activity and a prenatal diagnosis |
Q66979017 | Mucolipidosis type IV: Ganglioside sialidase deficiency |
Q30313613 | Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in NEU1 gene causing sialidosis type I associated with mild to unspecific biochemical and enzymatic findings |
Q33940580 | Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex |
Q42501824 | Nephrosialidosis: ultrastructural and lectin histochemical study |
Q39682355 | Neuraminidase activity in liver and brain from patients with i-cell disease |
Q45130639 | Neuraminidase activity in the mucolipidoses (types I, II and III) and the cherry-red spot myoclonus syndrome |
Q67060032 | Neuraminidase deficiency in the cherry red spot-myoclonus syndrome |
Q66980431 | Neuraminidase deficiency in the mouse |
Q44925622 | Neuraminidase deficiency in the original patient with the Goldberg Syndrome |
Q72834626 | Neuraminidase deficiency presenting as non-immune hydrops fetalis |
Q66978399 | Neuraminidase in Cultured Fibroblasts and Leucocytes of Homozygotes and Heterozygotes for the Mucolipidosis II Gene (I-Cell Disease) |
Q39698667 | Neuraminidase in mucolipidoses: Normal activity in frozen autopsy tissues from three patients with I-cell disease and adult β-galactosidase deficiency |
Q44567585 | Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria |
Q44824438 | Oligosaccharide and Ganglioside Neuraminidase Activities of Mucolipidosis I (Sialidosis) and Mucolipidosis II (I-Cell Disease) Fibroblasts |
Q36649026 | Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis |
Q68372756 | Photoaffinity labeling of the lysosomal neuraminidase from bovine testis |
Q40245324 | Prenatal diagnosis of inherited metabolic diseases; principles, pitfalls, and prospects. |
Q39677198 | Progressive myoclonus epilepsy. A variant with probable X-linked inheritance |
Q70337852 | Purification and characterization of sialic acid containing materials accumulated in cultured skin fibroblasts from a patient with type II sialidosis |
Q35595384 | Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders |
Q88469040 | Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder |
Q33898281 | Sialidosis: a review of human neuraminidase deficiency |
Q42271895 | Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex |
Q67654120 | Structures of sialyl-oligosaccharides excreted in the urine of a patient with mucolipidosis I |
Q33264100 | The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin |
Q40156522 | The cherry-red spot-myoclonus syndrome |
Q70467704 | The simple detection of neuraminic acid-containing urinary oligosaccharides in patients with glycoprotein storage diseases |
Q54293746 | The synthesis of 4-methylumbelliferyl α-ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase |
Q39296453 | The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis |
Q28367281 | Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency |
Q40258751 | Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis |
Q40332474 | Urinary oligosaccharides in lysosomal and other metabolic disorders. |
Search more.